112 Where an application describes a nucleotide or amino acid sequence other than a sequence identified as forming part of the prior art, the sequence may not be amended unless
(a) the sequence listing is amended in accordance with sections 113 to 130;
(b) a copy of the amended sequence listing is filed in a computer-readable form that complies with section 131; and
(c) a statement is filed by the applicant with the Commissioner that the content of the copy of the amended sequence listing in computer-readable form is the same as the content of the amended sequence listing contained in the description.
- Date modified: